Cancer
Hepatocellular carcinoma in Nanchong
南充 肝细胞癌
1 hospital in Nanchong
Order: papers led on hepatocellular carcinoma, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for hepatocellular carcinoma: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Nanchong may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 35 papers ledNo open trial led
Hepatocellular carcinoma in every city Nanchong on the disease page, with the national map
open trial on hepatocellular carcinoma with a hospital in Nanchong
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 8 Nov 2026, with a listed hospital in Nanchong as lead sponsor or study site. 0 of them are led by a hospital in Nanchong. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingAnlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
- Phase
- Phase 3
- Started
- 2023-05
- Registry
- NCT05862337
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 43 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou, Hangzhou, Hefei, Jinan, Lanzhou, Luzhou, Nanchang, Nanchong, Nanning, Nantong, Ningbo, Shanghai, Shenyang, Taizhou, Tianjin, Urumqi, Wenzhou, Xi'an, Zhengzhou
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Nanchong
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| Affiliated Hospital of North Sichuan Medical College川北医学院附属医院 | 4 | 26 | 35 | 24 | none | none | none | none | 1 | 2 | none | 0 | none | none | none | none | none | none | none | none | none | 3 | 0 | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | 0 | none | none | none | none | none | none | |
| Nanchong Central Hospital南充市中心医院 | none | 4 | none | 34 open | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | |
| Nanchong Central Hospital, North Sichuan Medical College南充市中心医院 | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Nanchong.
- Nasopharyngeal carcinoma 4
- Oesophageal squamous cell carcinoma 26
- Hepatocellular carcinoma 35
- Stomach cancer 24
- Gastrointestinal stromal tumour 1
- Neuroblastoma 2
- Multiple myeloma 0
- IgG4-related disease 3
- Myasthenia gravis 0
- Hepatic echinococcosis 1
- Primary sclerosing cholangitis 1
- Inherited epidermolysis bullosa 0
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for hepatocellular carcinoma.
Counts are listed hospitals only, not every hospital in each city.
- 58 kmSuining遂宁None listed for hepatocellular carcinoma
- 139 kmChongqing重庆5 hospitals for hepatocellular carcinoma
- 141 kmDazhouNone listed for hepatocellular carcinoma
- 154 kmMianyang绵阳None listed for hepatocellular carcinoma
- 191 kmChengdu成都5 hospitals for hepatocellular carcinoma
- 222 kmLuzhou泸州1 hospital for hepatocellular carcinoma
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Nanchong on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.